Solanezumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 15:54, 22 September 2009 (Fixed link). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Solanezumab
Monoclonal antibody
Type?
SourceHuman
Targetamyloid-β
Clinical data
ATC code
  • none
Identifiers
CAS Number
Chemical and physical data
FormulaC6396H9922N1712O1996S42
Molar mass144084.24 g·mol−1

Solanezumab (proposed INN) is a monoclonal antibody used as a neuroprotector.[1]

References

  1. ^ International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy), World Health Organization.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Template:Humanizedmonoclonals

Retrieved from "https://en.wikipedia.org/w/index.php?title=Solanezumab&oldid=315527667"